Showing 1 to 20 of 367 approvalsPage 1 of 19

LEVETIRACETAM TEVA TABLETS 250MG

Approval: Dec 30, 2022

TEVA PHARMACEUTICAL HONG KONG LIMITED

DIOXOFIN CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/10ML

Approval: Dec 29, 2022

THE INTERNATIONAL MEDICAL COMPANY LIMITED

OMEGAFLEX PLUS EMULSION FOR INFUSION

Approval: Dec 29, 2022

B BRAUN MEDICAL SA

DIOXOFIN CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/40ML

Approval: Dec 29, 2022

THE INTERNATIONAL MEDICAL COMPANY LIMITED

DIOXOFIN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML

Approval: Dec 29, 2022

THE INTERNATIONAL MEDICAL COMPANY LIMITED

INESTOM PEDIATRIC ORAL SOLUTION 300MG/ML

Approval: Dec 22, 2022

HONG KONG MEDICAL SUPPLIES LIMITED

OMEPRAZOLE JEAN-MARIE GASTRO-RESISTANT CAPSULES 20MG

Approval: Dec 22, 2022

EUROPHARM LABORATOIRES COMPANY LIMITED

DAPTOMYCIN POWDER FOR SOLUTION FOR INJECTION/INFUSION 350MG

Approval: Dec 22, 2022

Pfizer Corporation Hong Kong Limited

PARADIN OPHTHALMIC SOLUTION 0.2% W/V

Approval: Dec 21, 2022

SB PHARMA LIMITED

TRAVOPROST-PHARMATHEN EYE DROPS 40MCG/ML

Approval: Dec 21, 2022

i & c (hong kong) limited

RAVICTI ORAL LIQUID 1.1G/ML

Approval: Dec 21, 2022

Hongkong WinHealth Pharma Group Co. Limited

♇ PAXLOVID TABLETS

Approval: Dec 21, 2022

Pfizer Corporation Hong Kong Limited

VORATEX TABLETS 50MG

Approval: Dec 21, 2022

SB PHARMA LIMITED

PALIPERIDONE PROLONGED-RELEASE TABLETS 9MG

Approval: Dec 21, 2022

i & c (hong kong) limited

CELECOR CAPSULES 200MG

Approval: Dec 21, 2022

SYNMOSA BIOPHARMA (HONG KONG) COMPANY LIMITED

PALIPERIDONE PROLONGED-RELEASE TABLETS 3MG

Approval: Dec 21, 2022

i & c (hong kong) limited

VORATEX TABLETS 200MG

Approval: Dec 21, 2022

SB PHARMA LIMITED

TRAVOPROST OPHTHALMIC SOLUTION 0.004% W/V

Approval: Dec 21, 2022

PRIMAL CHEMICAL COMPANY, LIMITED

ALSUNI CAPSULES 12.5MG

Approval: Dec 21, 2022

Lotus Pharmaceutical HK Limited

ALSUNI CAPSULES 50MG

Approval: Dec 21, 2022

Lotus Pharmaceutical HK Limited

• Prev
• 1
• 2
• 3
• 4
• 5
• 19
• Next